The National Institutes of Health (NIH), National Cancer Institute (NCI), annouces the 59th Regular Meeting of the Board of Scientific Advisors. The Board makes recommendations on research priorities conducted or supported by the Institute. This includes the evaluation of NCI awarded grants, cooperative agreements and contracts and concept review of those activities which it considers meritorious and consistent with the Institute's programs. The advisory role of the Board is scientific and does not include deliberation on matters of public policy.
Members of the public may attend in person. More information is available at the NCI's website.